People · Operator

John McFarland

Named in public records as an officer, director or promoter · active 2009–2026 · Other Health Care, Other Technology

2
Companies
2
Filings
$125.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
VantAI Holdings, Inc.Other Health CareSeries C$86.3M$475.3M2026
Magnachip Semiconductor LlcOther TechnologySeries B$39.5M$1.2B2009
Operator network

John McFarland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jason Pontin · 5 companies · 1 sharedJason PontinEvan Schwartz · 3 companies · 1 sharedEvan SchwartzZachary Carpenter · 2 companies · 1 sharedZachary CarpenterAlex Gasner · 1 companies · 1 sharedAlex GasnerMichael Elkins · 3 companies · 1 sharedMichael ElkinsH.K. Kim · 1 companies · 1 sharedH.K. KimMargaret Sakai · 1 companies · 1 sharedMargaret SakaiNader Tavakoli · 1 companies · 1 sharedNader TavakoliRandal Klein · 1 companies · 1 sharedRandal KleinSang Park · 1 companies · 1 sharedSang ParkSteven Tan · 1 companies · 1 sharedSteven TanTae Jong Lee · 1 companies · 1 sharedTae Jong LeeTae Young Hwang · 1 companies · 1 sharedTae Young HwangVantAI Holdings, Inc. · $86.3M raisedVantAI Holdings, Inc.Magnachip Semiconductor Llc · $39.5M raisedMagnachip Semiconduct…John McFarlandJM
John McFarland Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John McFarland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jason Pontin15
Evan Schwartz13
Michael Elkins13
Zachary Carpenter12
H.K. Kim11
Tae Jong Lee11
Sang Park11
Nader Tavakoli11
Tae Young Hwang11
Randal Klein11
Alex Gasner11
Margaret Sakai11
Steven Tan11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.